Valsynthese is a subsidiary of Société Suisse des Explosifs Group. Since its foundation in 1894, the group has acquired broad experience in the field of civil explosives, and since the seventies has gradually developed its expertise into hazardous and high energetic chemistry. Valsynthese is devoted to delivering high quality services to the pharmaceutical and chemical industry.

Valsynthese offers custom synthesis and contract manufacturing of chemical intermediates and APIs. The company provides customers with complete solutions from process development to industrial production and from preclinical to commercial quantities. Services include full regulatory support from process validation, stability testing to preparation of documents, such as CMC document and Drug Master File, required for registration.

Valsynthese is committed to ever greater levels of achievement in environmental and safety, as well as quality and regulatory compliance excellence.

Valsynthese core expertise in hazardous and high energetic chemistry comprises the following specific reactions: Bromination, Chlorination, Reaction with high pressure gasses such as isoprene, Nitration, Oxidation, Azide chemistry, Hydrogenation, Grignard and Nitroglycerine formulations.

Recently Valsynthese has broadened its technology platform with Phosgene chemistry. The versatility of Phosgene chemistry opens the door to a large range of new syntheses. Continuous in situ generation of Phosgene guarantees a high level of safety when producing on a commercial scale.

From development to production, Valsynthese matches the quality standards required by its customers. Valsynthese operates under two quality systems: cGMP certified by Swissmedic, the national Health Authority, or ISO 9001:2008 certified by SQS.

Valsynthese valorises its customers by providing high level services based on a competent and experienced human capital fully committed to developing competitive solutions in a safe environment with a strong ethical responsibility.

Valsynthese is the value added key partner for its customers in the pharmaceutical and chemical industry.